HCPCS M-Codes
Medical services

  • M1015

    Discharge/discontinuation of the episode of care documented in the medical record

  • M1016

    Female patients unable to bear children

  • M1017

    Patient admitted to palliative care services

  • M1018

    Patients with an active diagnosis or history of cancer (except basal cell and squamous cell skin carcinoma), patients who are heavy tobacco smokers, lung cancer screening patients

  • M1019

    Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5

  • M1020

    Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5. either phq-9 or phq-9m score was not assessed or is greater than or equal to 5

  • M1021

    Patient had only urgent care visits during the performance period

  • M1022

    Patients who were in hospice at any time during the performance period

  • M1023

    Adolescent patients 12 to 17 years of age with major depression or dysthymia who reached remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five

  • M1024

    Adolescent patients 12 to 17 years of age with major depression or dysthymia who did not reach remission at six months as demonstrated by a six month (+/-60 days) phq-9 or phq-9m score of less than five. either phq-9 or phq-9m score was not assessed or is greater than or equal to five
  • Continued

  • M1025

    Patients who were in hospice at any time during the performance period

  • M1026

    Patients who were in hospice at any time during the performance period

  • M1027

    Imaging of the head (ct or mri) was obtained

  • M1028

    Documentation of patients with primary headache diagnosis and imaging other than ct or mri obtained

  • M1029

    Imaging of the head (ct or mri) was not obtained, reason not given

  • M1030

    Patients with clinical indications for imaging of the head

  • M1031

    Patients with no clinical indications for imaging of the head

  • M1032

    Adults currently taking pharmacotherapy for oud

  • M1033

    Pharmacotherapy for oud initiated after june 30th of performance period

  • M1034

    Adults who have at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days

  • M1035

    Adults who are deliberately phased out of medication assisted treatment (mat) prior to 180 days of continuous treatment

  • M1036

    Adults who have not had at least 180 days of continuous pharmacotherapy with a medication prescribed for oud without a gap of more than seven days

  • M1037

    Patients with a diagnosis of lumbar spine region cancer at the time of the procedure

  • M1038

    Patients with a diagnosis of lumbar spine region fracture at the time of the procedure

  • M1039

    Patients with a diagnosis of lumbar spine region infection at the time of the procedure

  • M1040

    Patients with a diagnosis of lumbar idiopathic or congenital scoliosis

  • M1041

    Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis

  • M1042

    Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

  • M1043

    Functional status was not measured by the oswestry disability index (odi version 2.1a) at one year (9 to 15 months) postoperatively

  • M1044

    Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively
  • Continued

  • M1045

    Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was greater than or equal to 37 or knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was greater than or equal to 71

  • M1046

    Functional status measured by the oxford knee score (oks) at one year (9 to 15 months) postoperatively was less than 37 or the knee injury and osteoarthritis outcome score joint replacement (koos, jr.) was less than 71 postoperatively

  • M1047

    Functional status was measured by the oxford knee score (oks) patient reported outcome tool within three months preoperatively and at one year (9 to 15 months) postoperatively

  • M1048

    Functional status measurement with score was obtained utilizing the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively

  • M1049

    Functional status was not measured by the oswestry disability index (odi version 2.1a) at three months (6 - 20 weeks) postoperatively

  • M1050

    Functional status was measured by the oswestry disability index (odi version 2.1a) patient reported outcome tool within three months preoperatively and at three months (6 to 20 weeks) postoperatively

  • M1051

    Patient had cancer, acute fracture or infection related to the lumbar spine or patient had neuromuscular, idiopathic or congenital lumbar scoliosis

  • M1052

    Leg pain was not measured by the visual analog scale (vas) or numeric pain scale at one year (9 to 15 months) postoperatively

  • M1053

    Leg pain was measured by the visual analog scale (vas) within three months preoperatively and at one year (9 to 15 months) postoperatively

  • M1054

    Patient had only urgent care visits during the performance period

  • M1055

    Aspirin or another antiplatelet therapy used

  • M1056

    Prescribed anticoagulant medication during the performance period, history of gi bleeding, history of intracranial bleeding, bleeding disorder and specific provider documented reasons: allergy to aspirin or anti-platelets, use of non-steroidal anti-inflammatory agents, drug-drug interaction, uncontrolled hypertension > 180/110 mmhg or gastroesophageal reflux disease

  • M1057

    Aspirin or another antiplatelet therapy not used, reason not given

  • M1058

    Patient was a permanent nursing home resident at any time during the performance period

  • M1059

    Patient was in hospice or receiving palliative care at any time during the performance period

  • M1060

    Patient died prior to the end of the performance period

  • M1061

    Patient pregnancy

  • M1062

    Patient immunocompromised

  • M1063

    Patients receiving high doses of immunosuppressive therapy

  • M1064

    Shingrix vaccine documented as administered or previously received